Download presentation
Presentation is loading. Please wait.
Published byOswald Kelley Modified over 9 years ago
1
Why tethered-ligand technology? It is easy to bind targets to microarrays, but in order to detect interactions, the fluorescence of a spot must either increase or decrease Detection is easy for genomic microarrays – standard DNA/RNA enzymatic methods amplify and fluorescently label nucleic acid samples Detection is very difficult for proteomic microarrays –no equivalent enzymatic amplification and duplication methods Direct chemical labeling methods are unsatisfactory
2
Labeling: genomic vs proteomic Genomic microarray Sample: Amplification and labeling Binding: Proteomic microarray
3
Chemical labeling can change protein-target interactions Sample: Binding: Labeling: Without labelingWith labeling
4
How to detect binding of unlabeled proteins and ligands? Want to simply take a cell extract or diagnostic sample, dump it on a microarray, and go The microarray itself must contain the detection means in an inactive state
5
Tethered-ligand detection techniques Relies on fluorescence resonance transfer (FRET) technology An FRET labeled receptor- ligand reagent is prebound to the microarray Analytes are detected as they perturb the bound receptor-ligand pair Tether Receptor Ligand
6
Miyata’s Antigen-Ab hydrogels Nature 399, 766 - 769 (1999)
7
What is fluorescence resonance transfer (FRET) technology? Dye 1 Dye 2 RoRo Energy transfer between two dye molecules R o distance is typically between 40 to 90 angstroms Commonly used technique
8
Tethered-ligand chemistry Here, a labeled ligand is displaced from a receptor by an unlabeled “test sample” ligand
9
Enzymatic detection -P Here, a kinase phosphorylates a group, abolishing target binding, and creating a fluorescent signal.
10
General purpose reagent platform? Cover microarray surface with FRET coupled Avidin and 2 nd antibody In selected locations, bind biotinated ligand – 1 st antibody complex Addition of unlabeled ligand will abolish Avidin – 2 nd antibody FRET
11
Tetered-ligand patent application 20030108972 A1 Concept of tethered-ligand methods for all microarray applications All detection methodologies and enzymatic types claimed Specific applications for proteases, kinases, sepsis, apoptosis, angiogenesis
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.